Free Trend Report Free 2018 Report & eBook

Get the top 100 trends happening right NOW -- plus a FREE copy of our award-winning book.

Keynotes.org Our Research Methodology

This article is one of 350,000 experiments. We use crowd filtering, big data and AI to identify insights.

Cornell University's Nicotine Vaccine Curbs the Habit for Good

 - Jun 29, 2012
References: weill.cornell.edu & gizmag
It has been said that quitting smoking can be more difficult than trying to quit heroin, and if the Nicotine Vaccine developed by researchers at Cornell University's Medical College fulfills its promise -- life-long smokers will be able to curb their addition for good.

While thus far it has only been tested on mice, the results have been promising. The vaccine works in the kidneys, pumping the nicotine out of one's body before it has the chance to make it to one's brain and provide that addictive rush that gets people hooked.

The effects of a single dose can last for a lifetime and has also been reported to prevent non-smokers from ever becoming addicted in the first place.